Society of Hematologic Oncology Annual Meeting | Conference

Adaptive Therapies and Novel Targets Will Play a Notable Role in the Future Treatment of Polycythemia Vera, Expert Says
September 15, 2021

Francesco Passamonti, MD, discusses the future of treatment for patients with polycythemia vera such as adaptive therapies and the utilization of novel targets.

Pirtobrutinib Yields Promising Responses in Previously Treated CLL/SLL
September 13, 2021

Patients with previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma appeared to benefit from treatment with pirtobrutinib.

Pirtobrutinib Demonstrates Strong Response Rates for Previously Treated CLL/SLL
September 11, 2021

Strong response rates were observed with pirtobrutinib across dose levels to treat patients with chronic lymphocytic leukemia and small lymphocytic lymphoma ion a phase 1/2 study.